MedTrace Logo

Deoxyhemoglobin Concentration Changes and Cerebral Perfusion Imaging

NCT04537611 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-04-27

No results posted yet for this study

Summary

To investigate a new method to rapidly modulate pulmonary venous hemoglobin oxygen saturation to enable the use of deoxyhemoglobin concentration in arterial blood as an intra-arterial MRI contrast agent for cerebral tissue perfusion imaging.

Conditions

  • Stenosis, Carotid
  • Stroke
  • Neurovascular Disorder

Interventions

DIAGNOSTIC_TEST

dHb contrast and gadolinium contrast imaging

see arm description

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • David Mikulis · Univeristy Health Network

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2021-09-30
Completion
2022-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04537611 on ClinicalTrials.gov